Glycosylated haemoglobin assay

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5242842
SERIAL NO

07613505

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of assessing glycosylated haemoglobin in a sample, wherein the method comprises the steps of (a) contacting the sample with signal-forming molecules comprising a conjugate of one or more dihydroxyboryl residues or salts thereof, linked to a signal-forming label; (b) separating by selective precipitation from a homogenous solution, glycosylated and non-glycosylated haemoglobin and any molecules bound thereto, from the reaction mixture of step (a) above; and (c) assessing signal-forming molecules selected from the group consisting of signal-forming molecules which have bound to the separated haemoglobin, and non-haemoglobin bound signal-forming molecules. Steps (a) and (b) may be performed simultaneously or sequentially. The sample may optionally be haemolyzed to liberate any cell bound haemoglobin. The invention also comprises an analytical test kit for use in accordance with the method of the invention. The new assay of the invention is particularly useful for the in vitro diagnosis and monitoring of diabetes mellitus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AXIS-SHIELD ASANORWAY RUODEKA SANDE MORE OG ROMSDAL

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sundrehagen, Erling Oslo, NO 41 384

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation